The bronchodilator salbutamol is associated with increased adverse cardiovascular outcomes in a pre-clinical heart attack model

Afthab Hussain

    Research output: Contribution to conferencePoster

    Original languageEnglish
    Publication statusPublished - 25 Mar 2011
    EventBPS Personalised Medicine meeting - Coventry, United Kingdom
    Duration: 24 Mar 201125 Mar 2011

    Conference

    ConferenceBPS Personalised Medicine meeting
    CountryUnited Kingdom
    CityCoventry
    Period24/03/1125/03/11

    Cite this

    Hussain, A. (2011). The bronchodilator salbutamol is associated with increased adverse cardiovascular outcomes in a pre-clinical heart attack model. Poster session presented at BPS Personalised Medicine meeting, Coventry, United Kingdom.